The Sympathetic Nervous System in Acute and Chronic Blood Pressure Elevation

Hypertension

Volumn , Issue , 2005, Pages 60-76

  Izzo, Joseph L ^a,b,c  

^a Departments of Pharmacology and Therapeutics   (United States)

^b Clinical Pharmacology Division   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884892376     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50096-X     Document Type: Chapter

References (273)

1. Izzo JL The sympathoadrenal system in the maintenance of elevated arterial pressure. J Cardiovasc Pharmacol 1984, 6:S514-S521.
2. Izzo JL Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage. Am J Hypertens 1989, 2:305S-312S.
3. Reis DJ The brain and hypertension: reflections on 35 years of inquiry into the neurobiology of the circulation. Circulation 1984, 70(Suppl III):31-45.
4. Reis DJ, Ruggiero DA, Morrison SF The C1 area of the rostral ventrolateral medulla oblongata. Am J Hypertens 1989, 2:363S-374S.
5. Ross CA, Ruggiero DA, Park DH, et al. Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate and plasma catecholamines and vasopressin. J Neurosci 1984, 4:474-494.
6. Abboud FM The sympathetic system in hypertension. Hypertension 1982, 4(Suppl II):208-225.
7. Walker JL, Abboud FM, Mark AL, et al. Interaction of cardiopulmonary and somatic reflexes in humans. J Clin Invest 1980, 65:1491-1497.
8. Ferrario CM, Barnes KL, Bohonek S Neurogenic hypertension produced by lesions of the nucleus tractus solitarii alone or with sinoaortic denervation in the dog. Hypertension 1981, 3(Suppl 2):112-118.
9. Nathan MA, Reis DJ Chronic labile hypertension produced by lesions of the nucleus tractus solitarri in the cat. Circ Res 1977, 40:72-80.
10. Ciriello J, Calaresu FR Projections from buffer nerves to the nucleus of the solitary tract: an anatomical and electrophysiological study in the cat. J Auton Nerv Syst 1981, 3:299-310.
11. Fink GD, Haywood JR, Bryan WJ, et al. Central site for pressor action of blood-borne angiotensin in rat. Am J Physiol 1980, 239:R358-R361.
12. Lumbers ER, McCloskey DI, Potter EK Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 1979, 294:69-80.
13. Fink GD, Bruner CA, Mangiapane ML Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 1987, 9:355-361.
14. Mangiapane ML, Skoog KM, Rittenhouse P, et al. Lesion of the area postrema region attenuates hypertension in spontaneously hypertensive rats. Circ Res 1989, 64:129-135.
15. Lee RM, Borkowski KR, Leenen FH, et al. Interaction between sympathetic nervous system and adrenal medulla in the control of cardiovascular changes in hypertension. J Cardiovasc Pharmacol 1991, 17(Suppl 2):S114-S116.
16. Nathan MA, Reis DJ Fulminating arterial hypertension with pulmonary edema from release of adrenomedullary catecholamines after lesions of the anterior hypothalamus in the rat. Circ Res 1975, 37:226-235.
17. Granata AR, Ruggiero DA, Park DH, et al. Brain stem area with C1 epinephrine neurons mediates baroreflex vasodepressor responses. Am J Physiol 1985, 248:H547-H567.
18. Bruner CA, Mangiapane ML, Fink GD, et al. Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats. Hypertension 1988, 11:668-673.
19. Juskevich JC, Robinson DS, Whitehorn D Effect of hypothalamic stimulation in spontaneously hypertensive and Wistar-Kyoto rats. Eur J Pharmacol 1978, 51:429-439.
20. Takeda K, Bunag RD Sympathetic hyperactivity during hypothalamic stimulation in spontaneously hypertensive rats. J Clin Invest 1978, 62:642-648.
21. Knuepfer MM, Johnson AK, Brody MJ Identification of brain stem projections mediating hemodynamic responses to stimulation of the anteroventral third ventricle (AV3V) region. Brain Res 1984, 294:305-314.
22. Knuepfer MM, Johnson AK, Brody MJ Vasomotor projections from the antero ventral third ventricle (AV3V). Am J Physiol 1984, 247:139-145.
23. Mangiapane ML, Brody MJ Vasoconstrictor and vasodilator sites within anteroventral third ventricle region. Am J Physiol 1987, 253:827-831.
24. Stratton JR, Halter JB Effect of a benzodiazepine (alprazolam) on plasma epinephrine and norepinephrine levels during exercise stress. Am J Cardiol 1985, 56:136-139.
25. Sasaki S, Nakata T, Kawasaki S, et al. Chronic central GABAergic stimulation attenuates hypothalamic hyperactivity and development of spontaneous hypertension in rats. J Cardiovasc Pharmacol 1990, 15(5):706-713.
26. Allen K, Shykoff BE, Izzo JL Cognitive appraisal of threat or challenge predicts hemodynamic responses to mental arithmetic and speech tasks. Am J Hypertens 1998, 11:134A.
27. Shykoff BE, Allen K, Izzo JL Interactions of social support and family history in blood pressure reactivity to psychological stressors. Am J Hypertens 1998, 11:134A.
28. Bunag RD, Eferakeya AD Immediate hypotensive after effects of posterior hypothalamic lesions in awake rats with spontaneous, renal, or DOCA hypertension. Cardiovasc Res 1976, 10:663-671.
29. Folkow BB, Johansson, Oberg B A hypothalamic structure with marked inhibitory effect on tonic sympathetic activity. Acta Physiol Scand 1959, 47:262-270.
30. Takeda K, Nakata T, Takesako T, et al. Sympathetic inhibition and attenuation of spontaneous hypertension by PVN lesions in rats. Brain Res 1991, 543(2):296-300.
31. Mangiarua EI, Lee RM Increased sympathetic innervation in the cerebral and mesenteric arteries of hypertensive rats. Can J Physiol Pharmacol 1990, 68(4):492-499.
32. Albert V, Campbell GR Relationship between the sympathetic nervous system and vascular smooth muscle: a morphometric study of adult and juvenile spontaneously hypertensive rat/Wistar-Kyoto rat caudal artery. Heart Vessels 1990, 5(3):129-139.
33. Brock JA, Van Helden DF, Dosen P, et al. Prevention of high blood pressure by reducing sympathetic innervation in the spontaneously hypertensive rat. J Auton Nerv Syst 1996, 61(2):97-102.
34. Antonaccio MJ, Robson RD, Burrell R The effects of L-dopa and alpha-methyldopa on reflexes and sympathetic nerve function. Eur J Pharmacol 1974, 25:9-18.
35. Falckh PH, Harkin LA, Head RJ Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1998, 19:541-545.
36. Gattone VH, Evan AP, Overhage JM, et al. Developing renal innervation in the spontaneously hypertensive rat: Evidence for a role of the sympathetic nervous system in renal damage. J Hypertens 1990, 8(5):423-428.
37. Cryer PE Physiology and Pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 1980, 303:436-444.
38. Rubin RP The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol Rev 1970, 22:389-428.
39. Iverson LL Catecholamine uptake process. Br Med Bull 1973, 29:130-135.
40. Dixon WR, Mosimann WF, Weiner N The role of presynaptic feedback mechanisms in regulation of norepinephrine release by nerve stimulation. J Pharmacol Exp Ther 1979, 209:196-204.
41. Langer SZ Pre-synaptic regulation of the release of catecholamines. Pharmacol Rev 1980, 32:337-362.
42. Rand MJ, Majewski H Adrenaline mediates a positive feedback loop in noradrenergic neurotransmission: its possible role in development of hypertension. Clin Exp Hypertens A 1984, 6:347-370.
43. Floras JS, Aylward PE, Victor RG, et al. Epinephrine facilitates neurogenic vasoconstriction in humans. J Clin Invest 1988, 81:1265-1274.
44. Chang PC, Kriek E, van Brummelen P Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. J Hypertens 1994, 12(2):179-190.
45. Draper AJ, Meghji S, Redfern PH Enhanced presynaptic facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. J Auton Pharmacol 1989, 9(2):103-111.
46. Bunag RD, Page IH, McCubbin JW Neural stimulation of release of renin. Circ Res 1966, 19:851-858.
47. Zimmerman BG Evaluation of peripheral and central components of action of angiotensin on the sympathetic nervous system. J Pharm Exp Ther, 1967, 158:1-10.
48. Zimmerman BG Adrenergic facilitation by angiotensin: does it serve a physiological function?. Clin Sci 1981, 60:343-348.
49. Marsden PA, Brenner BM, Ballerman BJ Mechanisms of angiotensin action on vascular smooth muscle, the adrenal, and the kidney. Hypertension: Pathophysiology, Diagnosis, and Treatment 1990, 1247-1272. Raven Press, New York. J.H. Laragh, B.M. Brenner (Eds.).
50. Waeber B, Brunner HR Cardiovascular hypertrophy: Role of angiotensin II and bradykinin. J Cardiovasc Pharmacol 1996, 27(Suppl 2):S36-S40.
51. Dzau VJ, Gibbons GH Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol 1988, 62:30G-35G.
52. Griffin SA, Brown WC, MacPherson F, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991, 17:626-635.
53. Gavras I, Mulinari R, Gavras H Renin-angiotensin and vasopressin in the development of salt-induced hypertension. J Hypertens 1988, 6:999-1002.
54. Ichihara A, Inscho EW, Imig JD, et al. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension 1997, 29(1 Pt 2):442-449.
55. Sander M, Hansen J, Victor RG The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-L-arginine methyl ester. Hypertension 1997, 30(1):64-70.
56. Zanzinger J, Czachurski J, Seller H Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res 1994, 75(6):1073-1077.
57. Tsuda K, Tsuda S, Goldstein M, et al. Effects of calcitonin gene-related peptide on [3H]norepinephrine release in medulla oblongata of spontaneously hypertensive rats. Eur J Pharmacol 1990, 191(1):101-105.
58. May CN, Whitehead CJ, Heslop KE, et al. Evidence that intravenous morphine stimulates central opiate receptors to increase sympatho-adrenal outflow and cause hypertension in conscious rabbits. Clin Sci(Lond) 1989, 76(4):431-437.
59. Feuerstein G, et al. Effect of morphine on the hemodynamic and neuroendocrine responses to hemorrhage in conscious rats. Circ Shock 1989, 27:219-235.
60. Shirakami G, Nakao K, Yamada T, et al. Inhibitory effect of brain natriuretic peptide on central angiotensin II-stimulated pressor response in conscious rats. Neurosci Lett 1988, 91:77-83.
61. Tsuchihashi T, Abe I, Fujishima M Role of metabotropic glutamate receptors in ventrolateral medulla of hypertensive rats. Hypertension 1994, 24(6):648-652.
62. Budzikowski AS, Huang BS, Leenen FH Brain "ouabain", a neurosteroid, mediates sympathetic hyperactivity in salt-sensitive hypertension. Clin Exp Hypertens 1998 1998, 20(2):119-140.
63. Huang BS, Yuan B, Leenen FH Chronic blockade of brain "ouabain" prevents sympathetic hyper-reactivity and impairment of acute baroreflex resetting in rats with congestive heart failure. Can J Physiol Pharmacol 2000, 78:45-53.
64. Lembo G, Rendina V, Iaccarino G, et al. Digitalis restores the forearm sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. J Hypertens 1993, 11:1395-1402.
65. Silverberg AB, Shah SD, Haymond MW, et al. Norepinephrine: Hormone and neurotransmitter in man. Am J Physiol 1978, 234(3):E252-E256.
66. Izzo JL Cardiovascular hormonal effects of circulating norepinephrine. Hypertension, 1983, 5:787-789.
67. Licht MR, Izzo JL Humoral effect of norepinephrine on renin release in humans. Am J Hypertens 1989, 2:788-791.
68. Sloand JA, Hooper M, Izzo JL Effects of circulating norepinephrine on platelets, leukocytes, and RBC counts by alpha-1 adrenergic stimulation. Am J Cardiol 1989, 63:1140-1142.
69. Clayton S, Cross MJ The aggregation of blood platelets by catecholamines and by thrombin. J Physiol(Lond), 1963, 169:82P-83P.
70. Vlachakis ND, Aledort L Hypertension and propranolol therapy: Effect on blood pressure, plasma catecholamines and platelet aggregation. Am J Cardiol 1980, 45:321-325.
71. Huang MH, Friend DS, Sunday ME, et al. An intrinsic adrenergic system in mammalian heart. J Clin Invest 1996, 98(6):1298-1303.
72. Abboud FM An intrinsic cardiac adrenergic system can regulate cardiac development and function. J Clin Invest 1996, 98(6):1275-1276.
73. Egan B, Panis R, Hinderliter A, et al. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987, 80:812-817.
74. Egan B, Schmouder R The importance of hemodynamic considerations in essential hypertension. Am Heart J 1988, 116(2 Pt 2):594-599.
75. Wilson MF, Sung BH, Pincomb GA, et al. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 1990, 66:731-736.
76. Julius S, Conway J Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968, 38:282-288.
77. Safar ME, Weiss YA, Levenson JA, et al. Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol 1973, 31:315-319.
78. Messerli FH, Frohlich ED, Suarez DH, et al. Borderline hypertension: Relationship between age, hemodynamics and circulating catecholamines. Circulation 1981, 64:760-764.
79. Chapleau MW, Hajduczok G, Abboud FM Paracrine role of prostanoids in activation of arterial baroreceptors: An overview. Clin Exper Hypertens A 1991, 13(5):817-824.
80. Sharma RV, Chapleau MW, Hajduczok G, et al. Mechanical stimulation increases intracellular calcium concentration in nodose sensory neurons. Neuroscience 1995, 66(2):433-441.
81. Chapleau MW, Lu J, Hajduczok G, et al. Mechanism of barore-ceptor adaptation in dogs: Attenuation of adaptation by the K+ channel blocker 4-aminopyridine. J Physiol 1993, 462:291-306.
82. Mancia G, Parati G, Pomidossi G, et al. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986, 8:147-153.
83. Izzo JL, Taylor AA The sympathetic nervous system and baroreflexes in hypertension and hypotension. Curr Hypertens Rep 1999, 1(3):254-263.
84. Goldstein DS Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation 1983, 68(2):234-240.
85. Matsukawa T, Gotoh E, Hasegawa O, et al. Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension. J Hypertension 1991, 9(6):537-542.
86. Hajduczok C, Chapleau MW, Abboud FM Increase in sympathetic activity with age. II. Role of impairment of cardiopulmonary baroreflexes. Am J Physiol 1991, 260:H1121-H1127.
87. Hajduczok G, Chapleau MW, Johnson SL, et al. Increase in sympathetic activity with age. I. Role of impairment of arterial baroreflexes. Am J Physiol 1991, 260(4 Pt 2):H1113-H1120.
88. Hajduczok G, Chapleau MW, Abboud FM Rapid adaptation of central pathways explains the suppressed baroreflex with aging. Neurobiol Aging 1991, 12(5):601-604.
89. Ebert TJ, Morgan BJ, Barney JA, et al. Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol 1992, 263(3 Pt 2):H798-H803.
90. Luft FC, Rankin LI, Henry DP, et al. Plasma and urinary norepinephrine at extremes of sodium intake in normal man. Hypertension 1979, 1:261-266.
91. Romoff MS, Keusch G, Campese VM, et al. Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab 1979, 48:26-31.
92. Thames MD, Johnson LN Impaired cardiopulmonary baroreflex control of renal nerves in renal hypertension. Circ Res 1985, 57:741-747.
93. Guo GB, Thames MD Abnormal baroreflex control in renal hypertension is due to abnormal baroreceptors. Am J Physiol 1983, 245:420-428.
94. Tidgren B, Hjemdahl P, Theodorsson E, et al. Renal responses to lower body negative pressure in humans. Am J Physiol 1990, 259:F573-F579.
95. Schmedtje JF, Varghese A, Gutkowska J, et al. Correlation of plasma norepinephrine and plasma atrial natriuretic factor during lower body negative pressure. Aviat Space Environ Med 1990, 61(6):555-558.
96. Joyner MJ, Shepherd JT, Seals DR Sustained increases in sympathetic outflow during prolonged lower body negative pressure in humans. J Appl Physiol 1990, 68:1004-1009.
97. Westheim A, Os I, Kjeldsen SE, et al. Renal haemodynamic and sympathetic responses to head-up tilt in essential hypertension. Scand J Clin Lab Invest 1990, 50(8):815-822.
98. Izzo JL, Sander E, Larrabee PS Effect of postural stimulation on systemic hemodynamics and sympathetic nervous activity in systemic hypertension. Am J Cardiol 1990, 65:339-342.
99. AU6]Modulation of carotid baroreflex responsiveness in man: Effects of posture and propranolol labetalol in long-term treatment of hypertension. J Appl Physiol 1976, 41:383-387.
100. Thames MD, Schmid PG Interaction between carotid and cardiopulmonary baroreflexes in control of plasma ADH. Am J Physiol 1981, 241:431-434.
101. Thames MD, Miller BD, Abboud FM Baroreflex regulation of renal nerve activity during volume expansion. Am J Physiol 1982, 243:810-814.
102. Blair ML, Chen Y-H, Hisa H Elevation of plasma renin activity by alpha-adrenoceptor agonists in conscious dogs. Am J Physiol 1986, 251(6 Pt 1):E695-E702.
103. Blair ML Stimulation of renin secretion by alpha-adrenoceptor agonists. Am J Physiol 1983, 244(1):E37-E44.
104. Osborn JL, Thames MD, DiBona GF Role of macula densa in renal nerve modulation of renin secretion. Am J Physiol 1982, 242:367-371.
105. Osborn JL, Roman RJ, Ewens JD Renal nerves and the development of Dahl salt-sensitive hypertension. Hypertension 1988, 11(6 Pt 1):523-528.
106. Osborn JL, Plato CF, Gordin E, et al. Long-term increases in renal sympathetic nerve activity and hypertension. [Review] [30 refs]. Clin Exper Pharmacol & Physiol 1997, 24(1):72-76.
107. DiBona GF Role of the renal nerves in hypertension. Sem Nephrol 1991, 11(5):503-511.
108. DiBona GF, Rios LL Renal nerves in compensatory renal response to contralateral renal denervation. Am J Physiol 1980, 238:F26-F30.
109. Johnson JA, Davis JO, Gotshall RW, et al. Evidence for an intrarenal beta receptor in control of renin release. Am J Physiol 1976, 230(2):410-418.
110. Kamm DE, Levinsky NG The mechanism of denervation natriuresis. J Clin Invest 1965, 44:93.
111. Gill JR, Mason DT, Bartter FC Adrenergic nervous system in sodium metabolism: Effects of guanethidine and sodium-retaining steroids in normal man. J Clin Invest 1964, 43:177.
112. Gill JR, Bartter FC Adrenergic nervous system in sodium metabolism. II. Effects of guanethidine on the renal response to sodium deprivation in normal man. N Engl J Med 1966, 275:1466-1471.
113. Wagner HN The influence of autonomic vasoregulatory reflexes on the rate of sodium and water excretion in man. J Clin Invest 1957, 36:1319-1327.
114. Matsuoka H, Nishida H, Nomura G, et al. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994, 23(6 Pt 2):971-975.
115. Xie PL, McDowell TS, Chapleau MW, et al. Rapid baroreceptor resetting in chronic hypertension. Implications for normalization of arterial pressure. Hypertension 1991, 17(1):72-79.
116. Gribbin B, Pickering TG, Sleight P, et al. Effect of age and high blood pressure on baroreflex sensitivity in man. Circulation Research 1971, 29(4):424-431.
117. Sleight P Importance of cardiovascular reflexes in disease. Am J Med 1988, 84(suppl 3A):92-96.
118. Randall OS, Esler MD, Bulloch EG, et al. Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med 1976, 51:357S-360S.
119. Pickering TG, Gribbin B, Oliver DO Baroreflex sensitivity in patients on long-term hemodialysis. Clin Sci 1972, 43:645-647.
120. Izzo JL, Smith RJ, Larrabee PS, et al. Plasma norepinephrine and age as determinants of systemic hemodynamics in men with established essential hypertension. Hypertension 1987, 9:415-419.
121. Simon AC, Safar ME, Weiss YA, et al. Baroreflex sensitivity and cardiopulmonary blood volume in normotensive and hypertensive patients. Br Heart J 1977, 39:799-805.
122. Mark AL, Kerber RE Augmentation of cardiopulmonary baroreflex control of forearm vascular resistance in borderline hypertension. Hypertension 1982, 39-46.
123. Rea RF, Hamdan M Baroreflex control of muscle sympathetic nerve activity in borderline hypertension. Circulation 1990, 82:856-862.
124. Saito M, Minokoshi Y, Shimazu T Metabolic and sympathetic nerve activities of brown adipose tissue in tube-fed rats. Am J Physiol 1989, 257(3 Pt 1):E374-E378.
125. Rothwell NJ, Stock MJ A role for brown adipose tissue in diet-induced thermogenesis. Obesity Res 1997, 5(6):650-656.
126. Landsberg L, Young JB Catecholamines and the adrenal medulla. Textbook of Endocrinology 1985, 891-965. WB Saunders, Philadelphia. J.D. Wilson, D.W. Foster (Eds.).
127. Kushiro T, Kobayashi F, Osada H, et al. Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension 1991, 17(6 Pt 2):965-968.
128. Andersson B, Elam M, Wallin BG, et al. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 1991, 18(6):783-789.
129. Izzo JL, Swislocki ALM Symposium on insulin and cardiovascular disease. Workshop III -Insulin resistance: Is it truly the link?. Am J Med 1991, 90(suppl 2A):26S-31S.
130. Bravo EL The metabolic effects of catecholamines. Am J Hypertens 1989, 2:338S-343S.
131. Kjeldsen SE, Rostrup M, Moan A, et al. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension. J Cardiovasc Pharmacol, 1992, 20(Suppl 8):S32-S36.
132. MacKenzie ET, McCulloch J, O'Kean M, et al. Cerebral circulation and norepinephrine: relevance of the blood-brain barrier. Am J Physiol 1976, 231:483-488.
133. Sadoshima S, Busija D, Brody M, et al. Sympathetic nerves protect against stroke in stroke-prone hypertensive rats. Hypertension 1981, 3:I124-I127.
134. Sadoshima S, Thames M, Heistad DD Cerebral blood flow during elevation of intracranial pressure: Role of sympathetic nerves. Am J Physiol 1981, 241:78-84.
135. Tuor UI Acute hypertension and sympathetic stimulation: local heterogeneous changes in cerebral blood flow. Am J Physiol 1992, 263:H511-H518.
136. Beroniade VC, Lefebvre R, Falardeau P Unilateral nodular diabetic glomerulosclerosis: Recurrence of an experiment of nature. Am J Nephrol 1987, 7:55-59.
137. Winder WW, Hagberg JM, Hickson RC, et al. Time course of sympathoadrenal adaptation to endurance exercise training in man. J Appl Physiol 1978, 45:370-374.
138. Winder WW, Hickson RC, Hagberg JM, et al. Training-induced changes in hormonal and metabolic responses to sub-maximal exercise. J Appl Physiol 1979, 46:766-771.
139. Paffenbarger RS, Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986, 314:605-613.
140. Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic medication of smoking-associated hemodynamic and metabolic effects. N Engl J Med 1976, 295:573-577.
141. Harburg E, et al. Socioecological stressor areas and black-white blood pressure: Detroit. J Chronic Dis 1993, 26:595-611.
142. Sokolow M, Werdegar D, Kain HK, et al. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966, 34(2):279-298.
143. Perloff D, Sokolow M, Cowan R The prognostic value of ambulatory blood pressures. JAMA 1983, 249:2792-2798.
144. Pickering TG, Harshfield GA, Blank S, et al. Behavioral determinants of 24-hour blood pressure patterns in borderline hypertension. J Cardiovasc Pharmacol 1986, 8:S89-S92.
145. Clark LA, Denby L, Pregibon D, et al. A quantitative analysis of the effects of activity and time of day on the diurnal variations of blood pressure. J Chronic Dis 1987, 40:671-681.
146. Devereux RB, Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983, 3:470-476.
147. Schnall PL, Pieper C, Schwartz JE, et al. The relationship between 'job strain', workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. JAMA 1992, 263:1929-1935, 1990. Erratum in: JAMA 267(9):1209.
148. Schneider RH, Egan BM, Johnson EH, et al. Anger and anxiety in borderline hypertension. Psychosomatic Med 1986, 48:242-248.
149. Julius S, Petrin J Autonomic nervous and behavioral factors in hypertension. Hypertension: Pathophysiology, Diagnosis, and Management 1990, 2083-2090. Raven Press, New York. J.H. Laragh, B.M. Brenner (Eds.).
150. Alderman MH, Madhavan S, Ooi WL, et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991, 324:1098-1104.
151. Kapusta DR, Knardahl S, Koepke JP, et al. Selective central alpha-2 adrenoceptor control of regional haemodynamic responses to air jet stress in conscious spontaneously hypertensive rats. J Hypertens 1989, 7:189-194.
152. DiBona GF Stress and sodium intake in neural control of renal function in hypertension. Hypertension 1991, 17(4 Suppl):III2-I116.
153. DiBona GF, Sawin LL Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991, 260(2 Pt 2):R298-R305.
154. DiBona GF, Jones SY Acute environmental stress overrides cardiac volume receptor reflex in borderline hypertensive rats. J Hypertens 1995, 13(1):63-68.
155. DiBona GF, Jones SY, Sawin LL Reflex effects on renal nerve activity characteristics in spontaneously hypertensive rats. Hypertension 1997, 30(5):1089-1096.
156. Hollenberg NK, Williams GH, Adams DF Essential hypertension: Abnormal renal vascular and endocrine responses to a mild psychological stimulus. Hypertension 1981, 3:11-17.
157. Schmieder RE, Ruddel H, Schachinger H, et al. Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage. Behav Med 1993, 19:5-12.
158. Allen K, Shykoff B-E, Izzo JL Pet ownership, but not ACE inhibitor therapy, blunts home blood pressure responses to mental stress. Hypertension 2001, 38(4):815-820.
159. Panza JA, Epstein SE, Quyyumi AA Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991, 325:986-1039.
160. Watson RD, Hamilton CA, Reid JL, et al. Changes in plasma norepinephrine, blood pressure and heart rate during physical activity in hypertensive man. Hypertension 1979, 1(4):341-346.
161. Floras JS, Jones JV, Johnston JA, et al. Arousal and the circadian rhythm of blood pressure. Clin Sci Mol Med 1978, 55:395S-397S.
162. Floras JS, Hassan MO, Jones JV, et al. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988, 11:273-281.
163. Sundberg S, Kohvakka A, Gordin A Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens 1988, 6(5):394-396.
164. Feller RP, Hale HB. Human sympathoadrenal responsiveness in autumn, winter and spring. Technical document, Rep. SAM-TDR-63-46. Brooks Air Force Base, TX, USAF School of Aerospace Medicine, 1963.
165. Hata T, Ogihara T, Maruyama A, et al. The seasonal variation of blood pressure in patients with essential hypertension. Clin Exp Hypertens 1982, 3:341-354.
166. Izzo JL, Larrabee PS, Sander E, et al. Hemodynamics of seasonal adaptation. Am J Hypertens 1990, 3:405-407.
167. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985, 313:1315-1322.
168. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987, 316:1514-1518.
169. Argentino C, Toni D, Rasura M, et al. Circadian variation in the frequency of ischemic stroke. Stroke 1990, 21:387-389.
170. Bean WB, Mills CA Coronary occlusion, heart failure and environmental temperatures. Am Heart J 1938, 16:701-713.
171. Anderson T, Le Riche W Cold weather and myocardial infarction. Lancet 1970, i:291-296.
172. Protos A, Caracta A, Gross L The seasonal susceptibility to myocardial infarction. J Am Geriatr Soc 1971, 19:526-535.
173. Ely D, Caplea A, Dunphy G, et al. Spontaneously hypertensive rat Y chromosome increases indexes of sympathetic nervous system activity. Hypertension 1997, 29(2):613-618.
174. Kumai T, Tanaka M, Watanabe M, et al. Possible involvement of androgen in increased norepinephrine synthesis in blood vessels of spontaneously hypertensive rats. Jpn J Pharmacol 1994, 66(4):439-444.
175. Robertson D, Goldberg MR, Onrot J, et al. Isolated failure of autonomic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. N Engl J Med 1986, 314:1494-1497.
176. Masuo K, Mikami H, Ogihara T, et al. Differences in insulin and sympathetic responses to glucose ingestion due to family history of hypertension. Am J Hypertens 1996, 9(8):739-745.
177. Masuo K, Mikami H, Ogihara T, et al. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in young, nonobese Japanese population. Am J Hypertens 1997, 10(1):77-83.
178. Masuo K, Mikami H, Ogihara T, et al. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension 1998, 32(1):96-100.
179. Manuck SB, Polefrone JM, Terrell DF, et al. Absence of enhanced sympathoadrenal activity and behaviorally evoked cardiovascular reactivity among offspring of hypertensives. Am J Hypertens 1996, 9(3):248-255.
180. Takiyyuddin MA, Cervenka JH, Hsiao RJ, et al. Chromogranin A. Storage and release in hypertension. Hypertension 1990, 15:237-246.
181. Fredrickson M, Tuomisto M, Bergman-Losman B Neuroendocrine and cardiovascular stress reactivity in middle-aged normotensive adults with parental history of cardiovascular disease. Psychophysiology 1991, 28(6):656-664.
182. Ferrara LA, Moscato TS, Pisanti N, et al. Is the sympathetic nervous system altered in children with familial history of arterial hypertension?. Cardiology 1988, 75(3):200-205.
183. Ferrier C, Cox H, Esler M Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci (Lond) 1993, 84(2):225-230.
184. Noll G, Wenzel RR, Schneider M, et al. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation 1996, 93(5):866-869.
185. Calhoun DA, Mutinga ML, Wyss JM, et al. Muscle sympathetic nervous system activity in black and Caucasian hypertensive subjects. J Hypertens 1994, 12(11):1291-1296.
186. Miller SB, Ditto B Exaggerated sympathetic nervous system response to extended psychological stress in offspring of hypertensives. Psychophysiol 1991, 28(1):103-113.
187. Parmer RJ, Cervenka JH, Stone RA Baroreflex sensitivity and heredity in essential hypertension. Circulation 1992, 85:497-503.
188. Levy RL, et al. Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 1945, 129(9):585-588.
189. Louis WJ, Doyle AE, Anavekar S Plasma norepinephrine levels in essential hypertension. N Engl J Med 1973, 288:599-601.
190. Goldstein DS Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983, 5:86-99.
191. Horky K, Kopecka J, Greogorova I, et al. Relationship between plasma renin activity and urinary catecholamines in various types of hypertension. Endokrinologie 1976, 67:331-342.
192. Januszewicz W, Wocial B Urinary excretion of catecholamines and their metabolites in patients with renovascular hypertension. Jpn Heart J 1978, 19:468-478.
193. Saito I, Takeshita E, Hayashi S, et al. Comparison of clinic and home blood pressure levels and the role of the sympathetic nervous system in clinic-home differences. Am J Hypertens 1990, 3:219-224.
194. Julius S, Krause L, Schork NJ, et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991, 9(1):77-84.
195. Hofman A, Boomsma F, Schalekamp MA, et al. Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population. Br Med J 1979, 1:1536-1538.
196. Kjeldsen SE, Zweifler AJ, Petrin J, et al. Sympathetic nervous system involvement in essential hypertension: Increased platelet noradrenaline coincides with decreased beta-adrenore-ceptor responsiveness. Blood Press 1994, 3(3):164-171.
197. Esler MD, Jennings GL, Johns J, et al. Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. J Hypertens Suppl 1984, 2(3):S123-S125.
198. Esler M, Lambert, Jennings C Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens Suppl 1990, 8:S53-S57.
199. Esler M, Ferrier C, Lambert G, et al. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension 1991, 17(4 suppl):III29-III35.
200. Ferrier C, Esler MD, Eisenhofer G, et al. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 1992, 19(1):62-69.
201. Morlin C, Wallin BG, Eriksson BM Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiol Scand 1983, 119:117-121.
202. Wallin BG, Morlin, Hjemdahl P Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects. Acta Physiol Scand 1987, 129:489-497.
203. Wallin BG, Thompson JM, Jennings GL, et al. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996, 491(Pt 3):881-887.
204. Vaz M, Jennings G, Turner A, et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 96(10):3423-3429.
205. Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995, 25(4 Pt 1):560-563.
206. Gudbjornsdottir S, Lonnroth P, Sverrisdottir YB, et al. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 1996, 27(2):276-280.
207. Ferranini E, Haffner SM, Stern MP Insulin sensitivity and hypertension. J Hypertens 1990, 8(suppl 7):S169-S173.
208. DeFronzo RA, Ferrannini E Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dys-lipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14(3):173-194.
209. Court JM, Hill GJ, Dunlop M, et al. Hypertension in childhood obesity. Aust Paediatr J 1974, 10:296-300.
210. Kannel WB, Brand N, Skinner JJ, et al. The relation of adiposity to blood pressure and development of hypertension: The Framingham study. Ann Intern Med 1976, 67:48-49.
211. Stamler R, Stamler J, Riedlinger WF, et al. Weight and blood pressure findings in hypertension screening of 1 million Americans. JAMA 1978, 240:1607-1610.
212. Sowers JR, Whitfield LA, Catania RA, et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982, 54:1181-1186.
213. Daly PA, Landsberg L Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Diabetes Care 1991, 14(3):240-248.
214. Facchini FS, Stoohs RA, Reaven GM Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996, 9(10 Pt 1):1013-1017.
215. Reaven GM, Lithell H, Landsberg L Hypertension and associated metabolic abnormalities-The role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334(6):374-381.
216. Rowe JW, Young JB, Minaker KL, et al. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981, 30:219-225.
217. Petersen JS, DiBona GF Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats. Hypertension 1996, 27(3 Pt 2):619-625.
218. Jamerson K, Smith SD, Amerena JV, et al. Vasoconstriction with norepinephrine causes less forearm insulin resistance than a sympathetic reflex vasoconstriction. Hypertension 1994, 23:1006-1011.
219. Rocchini AP, Mao HZ, Babu K, et al. Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999, 33(1 Pt 2):548-553.
220. Suzuki M, Kimura Y, Tsushima M, et al. Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension 2000, 35(4):864-868.
221. Esler MD, Julius S, Randall OS, et al. Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol 1975, 36(5):708-715.
222. Esler MD, Nestel PJ Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. American J Cardiol 1973, 32(5):643-649.
223. DeQuattro V, Campese V, Miura Y, et al. Increased plasma catecholamines in high renin hypertension. Am J Cardiol 1976, 38:801-804.
224. Esler M, Julius S, Zweifler A, et al. Mild high-renin essential hypertension: neurogenic human hypertension?. N Engl J Med 1977, 296:405-411.
225. Schmieder RE, Veelken R, Schobel H, et al. Glomerular hyper-filtration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol 1997, 8(6):893-900.
226. Fukuda N, Hu WY, Teng J, et al. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 2002, 163(2):229-239.
227. Izzo JL Hypertension in the elderly: A pathophysiologic approach to therapy. J Am Geriatrics Soc 1982, 30:352-359.
228. O'Malley K, Docherty JR, Kelly JG Adrenoceptor status and cardiovascular function in aging. J Hypertens Suppl 1988, 6(1):S59-S62.
229. Ward KD, Sparrow D, Landsberg L, et al. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: The Normative Aging Study. J Hypertens 1996, 14(3):301-308.
230. Cerasola G, Cottone S, D'Ignoto G, et al. Sympathetic activity in borderline and established hypertension in the elderly. J Hypertens Suppl 1988, 6(1):S55-S58.
231. Esler M, Skews H, Leonard P, et al. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci (Lond) 1981, 60:217-219.
232. Sverrisdottir YB, Johannsson G, Jungersten L, et al. Is the somatotropic axis related to sympathetic nerve activity in healthy ageing men?. J Hypertens 2001, 19(11):2019-2024.
233. Dinenno FA, Jones PP, Seals DR, et al. Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol 2000, 278(4):H1205-H1210.
234. Grassi G, Seravalle G, Bertinieri G, et al. Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens 2000, 18(5):587-593.
235. Li ST, Holmes C, Kopin IJ, et al. Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluo-rodopamine PET scanning. J Nucl Med 2003, 44(10):1599-1603.
236. Freis ED Origins and development of antihypertensive treatment. Hypertension: Pathophysiology, Diagnosis, and Management 1990, 2093-2105. Raven Press, New York. J.H. Laragh, B.M. Brenner (Eds.).
237. Simon G, Kiowski W, Julius S Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther 1977, 22:293-298.
238. Nicholls MG, Julius S, Zweifler AJ Withdrawal of endogenous sympathetic drive lowers blood pressure in primary aldosteronism. Clin Endocrinol(Oxf) 1981, 15:253-258.
239. Goldstein DS, Levinson PD, Zimlichman R, et al. Clonidine suppression testing in essential hypertension. Ann Intern Med 1985, 102:42-49.
240. Campese VM, Romoff MS, Levitan D, et al. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981, 20:246-253.
241. Izzo JL, Santarosa RP, Larrabee PS, et al. Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans: Effects of clonidine. J Cardiovasc Pharmacol 1987, 10(suppl. 12):S225-S229.
242. Goldstein DS, Keiser HR Neural circulatory control in the hyperdynamic circulation syndrome. Am Heart J 1985, 109:387-390.
243. Izzo JL, Licht MR, Smith RJ, et al. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension. Am J Cardiol 1987, 60:303-308.
244. Buhler FR, Amann FW, Bolli P, et al. Elevated adrenaline and increased alpha-adrenoceptor-mediated vasoconstriction in essential hypertension. J Cardiovasc Pharmacol 1982, 4(Suppl 1):S134-S138.
245. Philipp T, Distler A, Cordes U Sympathetic nervous system and blood pressure control in essential hypertension. Lancet 1978, 2:959-963.
246. Kiowski W, van Brummelen P, Buhler FR Plasma noradrenaline correlates with alpha-adrenoceptor-mediated vasoconstriction and blood pressure in patients with essential hypertension. Clin Sci (Lond) 1979, 57:177S-180S.
247. Rudner XL, Berkowitz DE, Booth JV, et al. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 1999, 100(23):2336-2343.
248. Pratt JH, Manatunga AK, Bowsher RR, et al. The interaction of norepinephrine excretion with blood pressure and race in children. J Hypertens 1992, 10:93-96.
249. Stepniakowski KT, Lu G, Miller GD, et al. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension 1997, 30(5):1150-1155.
250. Stansberry KB, Hill MA, Shapiro SA, et al. Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care 1997, 20(11):1711-1716.
251. Davy KP, Seals DR, Tanaka H Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension 1998, 32(2):298-304.
252. Dinenno FA, Dietz NM, Joyner MJ Aging and forearm postjunctional alpha-adrenergic vasoconstriction in healthy men. Circulation 2002, 106:1349-1354.
253. Drolet G, Bouvier M, de Champlain J Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats. J Hypertens 1989, 7:237-242.
254. Chen YF, Nagahama S, Winternitz SR, et al. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats. Am J Physiol 1985, H71-H79.
255. Zambraski EJ, Ciccone CD, Izzo JL The role of the sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine. Clin Exp Hypertens A 1986, 8:411-424.
256. Thomas GD, O'Hagan KP, Zambraski EJ Chemical sympathectomy alters the development of hypertension in miniature swine. Hypertension 1991, 17(3):357-362.
257. Moreau P, Drolet G, Yamaguchi N, et al. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension. Am J Hypertens 1993, 6:1016-1024.
258. Saavedra JM Brain catecholamines during development of DOCA-salt hypertension in rats. Brain Res 1979, 179:121-127.
259. Veelken R, Hilgers KF, Ditting T, et al. Impaired cardiovascular reflexes precede deoxycorticosterone acetate-salt hypertension. Hypertension 1994, 24(5):564-570.
260. Katholi RE, Winternitz SR, Oparil S Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 1981, 3:404-409.
261. Katholi RE, Whitlow PL, Winternitz SR, et al. Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension in the rat. Hypertension 1982, 4:166-174.
262. Eide I, Myers MR, DeQuattro V, et al. Increased hypothalamic noradrenergic activity in one-kidney one-clip renovascular hypertensive rats. J Cardiovasc Pharmacol 1980, 2:833-841.
263. Winternitz SR, Katholi RE, Oparil S Decrease in hypothalamic norepinephrine content following renal denervation in the one-kidney one-clip Goldblatt hypertensive rat. Hypertension 1982, 4:369-373.
264. Katholi RE, Winternitz SR, Oparil S Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest 1982, 69:55-62.
265. Dargie HL, Franklin SS, Reid JL The sympathetic nervous system in renovascular hypertension in the rat. Br J Pharmacol 1976, 56:365-374.
266. Wyss JM, Aboukarsh N, Oparil S Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol 1986, 250:H82-H86.
267. Wyss JM, Aboukarsh N, Oparil S Selective lesion of the renal afferents transiently lowers blood pressure in established 1 kidney, 1 clip Goldblatt hypertension. Circulation 1984, 70:429-435.
268. Izzo JL, Campese VM Hypertension and renal disease. Brenner and Rector's The Kidney 2004, 2109-2138. Saunders, Philadelphia. B.M. Brenner (Ed.).
269. Izzo JL, Sterns RH Abnormal norepinephrine release in uremia. Kidney Int 1983, 24(suppl.16):S221-S223.
270. Converse RL, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992, 327:1912-1918.
271. Campese VM Neurogenic factors and hypertension in chronic renal failure. J Nephrol 1997, 10(4):184-187.
272. Bravo EL, Tarazi RC, Fouad FM, et al. Clonidine-suppression test: A useful aid in the diagnosis of pheochromocytoma. N Engl J Med 1981, 305:623-626.
273. Schobel HP, Fischer T, Heuszer K, et al. Preeclampsia-a state of sympathetic overactivity. N Engl J Med 1996, 335:1480-1485.